Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorKunyue Li

About this trial

This study aims to explore the effect of intravenous vitamin C infusion on intrapartum fever after epidural labor analgesia, to reduce the impact of intrapartum fever on maternal and infant, improve maternal and infant outcomes, and provide a reference for clinical preventive medication.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

single-fetus, head position, and full-term vaginal delivery receiving epidural labor analgesia.

Disqualifiers

have a fever before epidural analgesia, acute infection on admission, incomplete baseline data, fatal fetal malformations or comorbidities, duration from admission to delivery of more than 72 hours or less than 3 hours, or an American Society of Anesthesiologists (ASA) classification of ≥ Ⅲ.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Vitamin C Injection

    Drug

    Drug Specification: 5ml: 1g. Method: parturients in each group will be intravenously injected with corresponding dose after receiving epidural labor analgesia.

  • Normal saline

    Other intervention

    The placebo comparator will receive normal saline with the same volume and be administered after the induction of epidural labor anesthesia.

Treatment groups

400 Participants
are divided into 4 treatment groups
Group A: Group C1Experimental treatment 1 intervention
Group B: Group C2Experimental treatment 1 intervention
Group C: Group C3Experimental treatment 1 intervention
Group D: Group PPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Intrapartum fever or not

The temperature of parturients ≥ 37.5℃

Time frame
Every two hours after receiving epidural labor analgesia, until baby delivery
2

The temperature of parturients

After receiving epidural labor analgesia

Time frame
Every two hours after receiving epidural labor analgesia, until baby delivery.
3

The duration of intrapartum fever

If parturients develop intrapartum fever, record the lasting time of fever.

Time frame
Every two hours after receiving epidural labor analgesia, until baby delivery.
4

Complete blood count indicators

Record the blood cell indicators for three times totally

Time frame
Take blood test immediately before analgesia, immediately when parturients is developing intrapartum fever and immediately after delivery

Secondary outcomes

1

Visual analogue scale(VAS)

Record the Visual analogue scale(VAS) of parturients at every time point. The visual analogue scale scores ranged from 0 to 10, with higher scores indicating increased pain levels.

Time frame
Every two hours after receiving epidural labor analgesia, until baby delivery.
2

Amount of total analgesics

Record the amount of total analgesics

Time frame
immediately After the baby is delivered
3

Side effects on mothers

Record the incidence of pruritus, vertigo, prosthesis, dyspnea, nausea and vomiting of parturients

Time frame
immediately After the baby is delivered
4

the duration of total labor

Delivery characteristics 1

Time frame
immediately After the baby is delivered

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kunyue Li

Lead sponsor

Third Affiliated Hospital of Zhengzhou University

Sponsor institution

Third Affiliated Hospital of Zhengzhou University

Collaborator